BlackRock Advisors’s West Pharmaceutical WST Stock Holding History

BlackRock Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.67M	Sell	43,297 -87,115	-67%	-$6.85M	﹤0.01%	1256
2016 Q3	$9.72M	Sell	130,412 -11,407	-8%	-$906K	0.01%	874
2016 Q2	$10.8M	Buy	141,819 +105,326	+289%	+$7.67M	0.01%	795
2016 Q1	$2.53M	Buy	36,493 +5,838	+19%	+$351K	﹤0.01%	1323
2015 Q4	$1.85M	Sell	30,655 -14,673	-32%	-$883K	﹤0.01%	1437
2015 Q3	$2.45M	Sell	45,328 -1,585	-3%	-$92.4K	﹤0.01%	1299
2015 Q2	$2.73M	Buy	46,913 +3,011	+7%	+$168K	﹤0.01%	1159
2015 Q1	$2.64M	Buy	43,902 +6,462	+17%	+$344K	﹤0.01%	1129
2014 Q4	$1.99M	Sell	37,440 -1,809	-5%	-$90.5K	﹤0.01%	1199
2014 Q3	$1.76M	Sell	39,249 -1,009	-3%	-$42.9K	﹤0.01%	1212
2014 Q2	$1.7M	Sell	40,258 -5,813	-13%	-$249K	﹤0.01%	1222
2014 Q1	$2.03M	Buy	46,071 +1,923	+4%	+$90.5K	﹤0.01%	1172
2013 Q4	$2.17M	Buy	44,148 +2,806	+7%	+$131K	﹤0.01%	1157
2013 Q3	$1.7M	Buy	41,342 +536	+1%	+$20.4K	﹤0.01%	1203
2013 Q2	$1.43M	Buy	+40,806	New	+$1.34M	﹤0.01%	1228

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Advisors's WST Position: Q4 2016 in Review

BlackRock Advisors reduced its West Pharmaceutical (WST) stake by 67% in Q4 2016, selling an estimated $6.85M and leaving 43,297 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

BlackRock Advisors first reported a position in WST in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.8M in Q2 2016. 287 funds tracked by Wall St. Rank hold WST as of Q4 2016.

BlackRock Advisors held 43,297 shares of West Pharmaceutical worth $3.67M as of Q4 2016.
BlackRock Advisors sold 87,115 West Pharmaceutical shares in Q4 2016, an estimated $6.85M.
West Pharmaceutical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1256 holding.
BlackRock Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's West Pharmaceutical position peaked at $10.8M in Q2 2016.
287 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.